How big is the sentinel lymph node biopsy imaging agents market?

The global sentinel lymph node biopsy imaging agents market size was estimated at USD 101.48 million in 2025 and is expected to reach USD 107.67 million in 2026.

What is the sentinel lymph node biopsy imaging agents market growth?

The global sentinel lymph node biopsy imaging agents market is expected to grow at a compound annual growth rate of 7.96% from 2026 to 2033 to reach USD 184.10 million by 2033.

Who are the key players in sentinel lymph node biopsy imaging agents market?

Some key players operating in the sentinel lymph node biopsy imaging agents market include Cardinal Health, Curium Pharma, Jubilant Pharmova, Guerbet, Diagnostic Green, Sun Pharmaceutical Industries, Inc., GE HealthCare, VIATRIS (Mylan Inc.), Macsen Labs, POLATOM, Hologic Inc. (Endomagnetic Ltd).

What are the factors driving the sentinel lymph node biopsy imaging agents market?

Key factors that are driving the market growth include the rising global burden of cancer, particularly breast cancer and melanoma, which increases the need for accurate staging and lymphatic mapping techniques.